NASSINI, ROMINA

NASSINI, ROMINA  

Scienze della Salute (DSS)  

Mostra records
Risultati 1 - 20 di 103 (tempo di esecuzione: 0.024 secondi).
Titolo Data di pubblicazione Autore(i) File
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. 2007 Trevisani M, Siemens J, Materazzi S, Bautista DM, Nassini R, Campi B, Imamachi N, Andrè E, Patacchini R, Cottrell GS, Gatti R, Basbaum AI, Bunnett NW, Julius D, Geppetti P.
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation. 2012 Baraldi PG, Romagnoli R, Saponaro G, Aghazadeh Tabrizi M, Baraldi S, Pedretti P, Fusi C, Nassini R, Materazzi S, Geppetti P, Preti D.
A bicarbonate-alkaline mineral water protects from ethanol-induced hemorrhagic gastric lesions in mice. 2010 Nassini R, Andrè E, Gazzieri D, De Siena G, Zanasi A, Geppetti P, Materazzi S.
A role for transient receptor potential vanilloid 4 in tonicity-induced neurogenic inflammation. 2010 Vergnolle N, Cenac N, Altier C, Cellars L, Chapman K, Zamponi GW, Materazzi S, Nassini R, Liedtke W, Cattaruzza F, Grady EF, Geppetti P, Bunnett NW.
Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents. 2010 Nassini R, Materazzi S, Andrè E, Sartiani L, Aldini G, Trevisani M, Carnini C, Massi D, Pedretti P, Carini M, Cerbai E, Preti D, Villetti G, Civelli M, Trevisan G, Azzari C, Stokesberry S, Sadofsky L, McGarvey L, Patacchini R, Geppetti P.
Activation of TRPA1 on dural afferents: a potential mechanism of headache pain 2012 Edelmayer RM, Le LN, Yan J, Wei X, Nassini R, Materazzi S, Preti D, Appendino G, Geppetti P, Dodick DW, Vanderah TW, Porreca F, Dussor G.
Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients 2017 Massi D; Romano E, Rulli E, Merelli B; Nassini R, De Logu F, Bieche I, Baroni G; Cattaneo L, Xue G, Mandalà M.
Caratterizzazione del ruolo fisiopatologico e funzionale del canali Transient Receptor Potential (TRP) nelle patologie dolorose di origine infiammatoria e neuropatica 2019 francesco de logu, Romina nassini, pierangelo Geppetti
Cigarette smoke-induced neurogenic inflammation is mediated by alpha,beta-unsaturated aldehydes and the TRPA1 receptor in rodents. 2008 Andrè E, Campi B, Materazzi S, Trevisani M, Amadesi S, Massi D, Creminon C, Vaksman N, Nassini R, Civelli M, Baraldi PG, Poole DP, Bunnett NW, Geppetti P, Patacchini R.
Cough sensors. II. Transient receptor potential membrane receptors on cough sensors 2009 Materazzi, S; Nassini, R; Gatti, R; Trevisani, M; Geppetti, P
Cough: The Emerging Role of the TRPA1 Channel. 2010 Geppetti P; Patacchini R; Nassini R; Materazzi S.
Dacarbazine alone or associated with melanoma-bearing cancer pain model induces painful hypersensitivity by TRPA1 activation in mice 2019 Brusco, Indiara; Li Puma, Simone; Chiepe, Kelly Braga; da Silva Brum, Evelyne; de David Antoniazzi, Caren Tatiane; de Almeida, Amanda Spring; Camponogara, Camila; Silva, Cássia Regina; De Logu, Francesco; de Andrade, Vanessa Moraes; Ferreira, Juliano; Geppetti, Pierangelo; Nassini, Romina; Oliveira, Sara Marchesan; Trevisan, Gabriela
Detrimental and Beneficial Effects of Ethanol by Stimulation of TRPV1 in Sensory Neurons 2008 S. Materazzi; R. Nassini; S. Benemei; S. Castellani; P. Geppetti
Digital immunophenotyping predicts disease free and overall survival in early stage melanoma patients 2021 De Logu F.; Galli F.; Nassini R.; Ugolini F.; Simi S.; Cossa M.; Miracco C.; Gianatti A.; De Giorgi V.; Rulli E.; Cossu A.; Massi D.; Mandala M.
Dupilumab for the treatment of recalcitrant eosinophilic dermatosis of haematologic malignancy 2021 Maglie R.; Ugolini F.; De Logu F.; Simi S.; Senatore S.; Montefusco F.; Nassini R.; Massi D.; Antiga E.
Functional characterization of human ProNGF and NGF mutants: Identification of NGF P61SR100E as a "Painless" lead investigational candidate for therapeutic applications 2015 Malerba F, Paoletti F, Ercole BB, Materazzi S, Nassini R, Coppi E, Patacchini R, Capsoni S, Lamba D, Cattaneo A.
Glutathione, glutathione disulfide, and S-glutathionylated proteins in cell cultures 2015 Giustarini D, Galvagni F, Tesei A, Farolfi A, Zanoni M, Pignatta S, Milzani A, Marone IM, Dalle-Donne I, Nassini R, Rossi R.
Immunomodulating property of MAPK inhibitors: From translational knowledge to clinical implementation 2017 Mandalà M, De Logu F, Merelli B, Nassini R, Massi D.
Involvement of PAR-2 in vitiligo 2007 S. Moretti; G. Baroni; A. Naldini; A. Simoni; F. Prignano; T. Lotti; F. Tarantini; S. Materazzi; R. Nassini; D. Massi
Keep in Mind TRPA1 When Prescribing Metamizole! 2016 Benemei S, Nassini R, Materazzi S, Geppetti P.